Get the Stockscreener App
112.71
0.71%
0.80
Pre-market:
111.03
-1.68
-1.49%
State Street Spdr S P Biotech Etf stock is traded at $112.71, with a volume of 13.01M.
It is up +0.71% in the last 24 hours and up +12.49% over the past month.
See More
Previous Close:
$111.91
Open:
$111.86
24h Volume:
13.01M
Relative Volume:
1.35
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.99%
1M Performance:
+12.49%
6M Performance:
+35.88%
1Y Performance:
+16.16%
1-Day Range:
$110.84
$113.01
1-Week Range:
$109.89
$113.21
52-Week Range:
$66.66
$113.21
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Name
State Street Spdr S P Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
112.71 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.42 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.06 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.23 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.99 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
629.07 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Stock (XBI) Latest News
It's a high-risk trade, but this biotech down 80% this year could be a buy - CNBC
Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin - Benzinga
Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView
StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market - Genetic Engineering and Biotechnology News
Have Biotech Stocks Returned To Health After Years Of Sickness? - Investor's Business Daily
Analyst Says He’s Buying This Biotech ETF, Predicts ‘Multi-Year’ Breakout - Insider Monkey
Guarantor: JPMorgan Chase & Co. - StreetInsider
Biotech Is Finally Rallying. Why Mizuho’s Jared Holz Is Optimistic This Time. - Barron's
XBI, CRSP, INSM, IONS: Large Inflows Detected at ETF - Nasdaq
The Technical Signals Behind (XBI) That Institutions Follow - news.stocktradersdaily.com
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Sahm
(XBI) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
(XBI) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Discipline and Rules-Based Execution in XBI Response - news.stocktradersdaily.com
String of acquisitions fuels biotech optimism - Sherwood News
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Truist Financial Corp Sells 5,213 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Vontobel Holding Ltd. Sells 7,846 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Price-Driven Insight from (XBI) for Rule-Based Strategy - news.stocktradersdaily.com
Behavioral Patterns of XBI and Institutional Flows - news.stocktradersdaily.com
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
Understanding Momentum Shifts in (XBI) - news.stocktradersdaily.com
Understanding the Setup: (XBI) and Scalable Risk - news.stocktradersdaily.com
(XBI) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Trading the Move, Not the Narrative: (XBI) Edition - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (XBI) Movement - news.stocktradersdaily.com
Ramirez Asset Management Inc. Sells 200 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Prime Capital Investment Advisors LLC Grows Stock Holdings in SPDR S&P Biotech ETF $XBI - Defense World
Why (XBI) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
SPDR S&P Biotech ETF declares quarterly distribution of $0.0267 - MSN
VanEck Biotech ETF (BBH): How to Buy - The Motley Fool
Janney Montgomery Scott LLC Decreases Stock Holdings in SPDR S&P Biotech ETF $XBI - Defense World
4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
SciSparc And AutoMax Call Off Merger - Sahm
Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. - Barron's
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
Responsive Playbooks and the XBI Inflection - news.stocktradersdaily.com
The Best Biotech ETFs to Buy - inkl
State Street Spdr S P Biotech Etf Stock (XBI) Financials Data
There is no financial data for State Street Spdr S P Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.09%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):